Lobbying client
CORTEXYME, INC.
Biopharmaceutical company for therapeutic approaches to degenerative diseases.
Filings
6
Filed by
1
Reported in-house
—
Reported by firms
$160,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2021 to 2022
Filings
1 filing for 2022, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Termination (No Activity) 1st Quarter 2022
|
TIBER CREEK GROUP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| TIBER CREEK GROUP | 5 | $160,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 3 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.